Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1973 1
1978 1
1980 4
1981 3
1982 1
1983 1
1984 2
1985 2
1986 1
1987 1
1988 3
1990 1
1991 1
1992 3
1993 6
1994 5
1995 6
1996 6
1997 10
1998 10
1999 12
2000 13
2001 6
2002 11
2003 3
2004 7
2005 2
2006 10
2007 4
2008 5
2009 4
2010 12
2011 11
2012 9
2013 12
2014 10
2015 12
2016 14
2017 11
2018 14
2019 10
2020 15
2021 12
2022 15
2023 12
2024 17
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

314 results

Results by year

Filters applied: . Clear all
Page 1
Comparative efficacy and safety of anifrolumab for belimumab-experienced and biologic-naïve patients with systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A, Doi G, Nakayama T, Maekawa M, Tsuru T, Akahoshi M, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: tsuru t. Joint Bone Spine. 2025 Jul;92(4):105882. doi: 10.1016/j.jbspin.2025.105882. Epub 2025 Mar 14. Joint Bone Spine. 2025. PMID: 40090613 No abstract available.
Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.
Ayano M, Ueda N, Mishima K, Ota SI, Kushimoto K, Tanaka A, Kawano S, Nishimura N, Kashiwado Y, Doi G, Nakayama T, Fukumoto R, Tsuru T, Suzaki M, Akahoshi M, Maekawa M, Omoto A, Tada H, Akashi K, Horiuchi T, Niiro H. Ayano M, et al. Among authors: tsuru t. Mod Rheumatol. 2024 Dec 25;35(1):102-109. doi: 10.1093/mr/roae058. Mod Rheumatol. 2024. PMID: 39096517
First-principles calculations on dislocations in MgO.
Kiyohara S, Tsuru T, Kumagai Y. Kiyohara S, et al. Among authors: tsuru t. Sci Technol Adv Mater. 2024 Aug 19;25(1):2393567. doi: 10.1080/14686996.2024.2393567. eCollection 2024. Sci Technol Adv Mater. 2024. PMID: 39229345 Free PMC article.
Effect of T cells on the complement production by monocytes.
Tsukamoto H, Nagasawa K, Ueda Y, Mayumi T, Yoshizawa S, Furugo I, Tsuru T, Niho Y. Tsukamoto H, et al. Among authors: tsuru t. Cell Immunol. 1993 Feb;146(2):382-90. doi: 10.1006/cimm.1993.1034. Cell Immunol. 1993. PMID: 8174176
Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RA.
Yamada H, Tsurui R, Kondo M, Fukushi JI, Sakuraba K, Miyamura T, Ishida M, Nakamura M, Inoue Y, Tsuru T, Shuto T, Yoshizawa S, Ohishi M, Kamo K, Haraguchi A, Maeyama A, Arinobu Y, Mitoma H, Ayano M, Ono N, Akasaki Y, Fujiwara T, Hara D, Arisumi S, Yasumoto K, Natori T, Niiro H, Nakashima Y. Yamada H, et al. Among authors: tsuru t. Mod Rheumatol. 2025 Sep 2;35(5):830-836. doi: 10.1093/mr/roaf037. Mod Rheumatol. 2025. PMID: 40341949
314 results